1. Home
  2. LTBR vs ANGO Comparison

LTBR vs ANGO Comparison

Compare LTBR & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightbridge Corporation

LTBR

Lightbridge Corporation

HOLD

Current Price

$13.01

Market Cap

578.2M

ML Signal

HOLD

Logo AngioDynamics Inc.

ANGO

AngioDynamics Inc.

HOLD

Current Price

$12.85

Market Cap

550.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTBR
ANGO
Founded
1992
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.2M
550.8M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
LTBR
ANGO
Price
$13.01
$12.85
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.33
AVG Volume (30 Days)
1.1M
415.5K
Earning Date
11-05-2025
01-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$300,718,000.00
Revenue This Year
N/A
$8.18
Revenue Next Year
N/A
$5.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.73
52 Week Low
$4.51
$8.27
52 Week High
$31.34
$13.99

Technical Indicators

Market Signals
Indicator
LTBR
ANGO
Relative Strength Index (RSI) 35.88 47.72
Support Level $12.95 $13.12
Resistance Level $15.19 $13.91
Average True Range (ATR) 1.04 0.35
MACD -0.01 -0.11
Stochastic Oscillator 3.02 7.83

Price Performance

Historical Comparison
LTBR
ANGO

About LTBR Lightbridge Corporation

Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Share on Social Networks: